U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 115

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr4:110667659
GRCh38:
Chr4:109746503
CFIAtypical hemolytic-uremic syndrome with I factor anomalyPathogenic
(Jul 4, 2023)
no assertion criteria provided
2.
GRCh38:
Chr1:196706898-196873196
CFH, LOC126805964, CFHR1, CFHR3Atypical hemolytic-uremic syndrome with I factor anomalyPathogeniccriteria provided, single submitter
3.
GRCh37:
Chr4:110682785
GRCh38:
Chr4:109761629
CFIFactor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly, Age related macular degeneration 13,
not provided
Likely benign
(Mar 4, 2022)
criteria provided, multiple submitters, no conflicts
4.
GRCh37:
Chr4:110663770
GRCh38:
Chr4:109742614
CFInot provided, Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly,
Age related macular degeneration 13
Likely benign
(Oct 17, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr4:110723116
GRCh38:
Chr4:109801960
CFInot provided, Factor I deficiency, Age related macular degeneration 13,
Atypical hemolytic-uremic syndrome with I factor anomaly
Likely benign
(Sep 19, 2022)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr4:110681722
GRCh38:
Chr4:109760566
CFIFactor I deficiency, Age related macular degeneration 13, Atypical hemolytic-uremic syndrome with I factor anomaly,
not provided
Likely benign
(Mar 11, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr4:110687846
GRCh38:
Chr4:109766690
CFInot provided, Atypical hemolytic-uremic syndrome with I factor anomaly, Factor I deficiency,
Age related macular degeneration 13
Likely benign
(Dec 29, 2021)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr4:110681746
GRCh38:
Chr4:109760590
CFInot provided, Atypical hemolytic-uremic syndrome with I factor anomaly, Factor I deficiency,
Age related macular degeneration 13
Likely benign
(Feb 26, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr4:110662145
GRCh38:
Chr4:109740989
CFIFactor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly, Age related macular degeneration 13,
not provided
Likely benign
(Feb 26, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr4:110685746
GRCh38:
Chr4:109764590
CFInot provided, Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly,
Age related macular degeneration 13
Likely benign
(Sep 19, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr4:110685686
GRCh38:
Chr4:109764530
CFIAge related macular degeneration 13, Atypical hemolytic-uremic syndrome with I factor anomaly, Factor I deficiency,
not provided
Likely benign
(Oct 19, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr4:110682801
GRCh38:
Chr4:109761645
CFIN177Inot provided, Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly,
Age related macular degeneration 13
Uncertain significance
(Jul 30, 2022)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr4:110681789
GRCh38:
Chr4:109760633
CFIS18Y, S221YAge related macular degeneration 13, Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly,
not provided
Uncertain significance
(Feb 18, 2022)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr4:110687845
GRCh38:
Chr4:109766689
CFIY65HFactor I deficiency, not provided, Age related macular degeneration 13,
Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly, Atypical hemolytic-uremic syndrome
Uncertain significance
(Sep 5, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr4:110667657
GRCh38:
Chr4:109746501
CFIA365T, A377T, A384T, A181T, A392Tnot provided, Age related macular degeneration 13, Factor I deficiency,
Atypical hemolytic-uremic syndrome with I factor anomaly
Uncertain significance
(Sep 17, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr4:110681679
GRCh38:
Chr4:109760523
CFIA258T, A55Tnot provided, Atypical hemolytic-uremic syndrome with I factor anomaly, Factor I deficiency,
Age related macular degeneration 13
Pathogenic/Likely pathogenic
(Oct 23, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr4:110667408
GRCh38:
Chr4:109746252
CFIC460R, C475R, C264R, C448R, C467RAtypical hemolytic-uremic syndrome with I factor anomaly, Age related macular degeneration 13, Factor I deficiency,
not provided
Uncertain significance
(May 9, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr4:110685837
GRCh38:
Chr4:109764681
CFIS113NAge related macular degeneration 13, Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly,
Atypical hemolytic-uremic syndrome, not provided
Uncertain significance
(Aug 19, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr4:110681461
GRCh38:
Chr4:109760305
CFID283G, D80GAge related macular degeneration 13, Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly,
not provided
Uncertain significance
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr4:110687908
GRCh38:
Chr4:109766752
CFID44NAge related macular degeneration 13, Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly,
not provided
Uncertain significance
(Jun 16, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr4:110682730
GRCh38:
Chr4:109761574
CFIR201GAge related macular degeneration 13, Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly,
not provided
Uncertain significance
(Apr 6, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr4:110670683
GRCh38:
Chr4:109749527
CFIR339Q, R347Q, R136Q, R320Q, R332Qnot provided, Age related macular degeneration 13, Factor I deficiency,
Atypical hemolytic-uremic syndrome with I factor anomaly
Uncertain significance
(Dec 23, 2021)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr4:110670459
GRCh38:
Chr4:109749303
CFIV336M, V355M, V363M, V348M, V152MAtypical hemolytic-uremic syndrome with I factor anomaly, Age related macular degeneration 13, Factor I deficiency,
Atypical hemolytic-uremic syndrome, not provided
Uncertain significance
(Jul 21, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr4:110687713
GRCh38:
Chr4:109766557
CFIE109KAtypical hemolytic-uremic syndrome with I factor anomaly, Age related macular degeneration 13, Factor I deficiency,
not provided
Uncertain significance
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr4:110663702
GRCh38:
Chr4:109742546
CFIS290R, S474R, S486R, S501R, S493RAtypical hemolytic-uremic syndrome with I factor anomaly, Age related macular degeneration 13, Factor I deficiency,
not provided
Uncertain significance
(Sep 9, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr4:110687758
GRCh38:
Chr4:109766602
CFIL94FAge related macular degeneration 13, Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly,
not provided
Uncertain significance
(Mar 29, 2022)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr4:110685736
GRCh38:
Chr4:109764580
CFIM147VAge related macular degeneration 13, Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly,
not provided
Uncertain significance
(Sep 7, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr4:110667591
GRCh38:
Chr4:109746435
CFIR203C, R399C, R414C, R406C, R387Cnot provided, Age related macular degeneration 13, Factor I deficiency,
Atypical hemolytic-uremic syndrome with I factor anomaly
Uncertain significance
(Oct 4, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr4:110667516
GRCh38:
Chr4:109746360
CFIA424S, A431S, A228S, A412S, A439SAge related macular degeneration 13, Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly,
not provided
Uncertain significance
(Jul 18, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr4:110681539
GRCh38:
Chr4:109760383
CFInot provided, Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly,
Age related macular degeneration 13
Uncertain significance
(Mar 22, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr1:196682885
GRCh38:
Chr1:196713755
CFHI453LAge related macular degeneration 4, Factor H deficiency, Hemolytic uremic syndrome, atypical, susceptibility to, 1,
Basal laminar drusen, Atypical hemolytic-uremic syndrome with I factor anomaly
Uncertain significance
(Nov 4, 2021)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr1:196658699
GRCh38:
Chr1:196689569
CFHI372VAtypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Jun 15, 2015)
criteria provided, single submitter
33.
GRCh37:
Chr4:110662163
GRCh38:
Chr4:109741007
CFIW343*, W527*, W539*, W546*, W554*Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly, Age related macular degeneration 13
Likely pathogenic
(Jun 30, 2021)
criteria provided, single submitter
34.
GRCh37:
Chr4:110681670-110681688
GRCh38:
Chr4:109760514-109760532
CFIFactor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly, Age related macular degeneration 13
Pathogenic
(Jun 30, 2021)
criteria provided, single submitter
35.
GRCh37:
Chr4:110670768
GRCh38:
Chr4:109749612
CFIAtypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Jan 4, 2021)
criteria provided, single submitter
36.
GRCh37:
Chr4:110685853-110685854
GRCh38:
Chr4:109764697-109764698
CFIAge related macular degeneration 13, Atypical hemolytic-uremic syndrome with I factor anomaly, Factor I deficiency,
not provided
Benign/Likely benign
(Oct 15, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr4:110667377
GRCh38:
Chr4:109746221
CFInot provided, Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome with I factor anomaly,
Age related macular degeneration 13, Factor I deficiency
Pathogenic/Likely pathogenic
(Oct 2, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr4:110687811
GRCh38:
Chr4:109766655
CFIA76Gnot provided, Atypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Feb 2, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr4:110663648
GRCh38:
Chr4:109742492
CFIAge related macular degeneration 13, Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly,
not provided
Uncertain significance
(Feb 27, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr4:110681732
GRCh38:
Chr4:109760576
CFIA240G, A37Gnot provided, Atypical hemolytic-uremic syndrome with I factor anomalyConflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
41.
GRCh37:
Chr4:110685802
GRCh38:
Chr4:109764646
CFIG125RAtypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
42.
GRCh37:
Chr4:110685751
GRCh38:
Chr4:109764595
CFIK142QAtypical hemolytic-uremic syndrome with I factor anomaly, Atypical hemolytic-uremic syndrome with I factor anomaly, Age related macular degeneration 13,
Factor I deficiency
Uncertain significance
(Feb 1, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr4:110682771
GRCh38:
Chr4:109761615
CFIR187QAtypical hemolytic-uremic syndrome with I factor anomaly, not providedConflicting interpretations of pathogenicity
(Jun 27, 2022)
criteria provided, conflicting interpretations
44.
GRCh37:
Chr4:110682728
GRCh38:
Chr4:109761572
CFIR201SAtypical hemolytic-uremic syndrome with I factor anomaly, not providedBenign/Likely benign
(Jul 17, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr4:110681528
GRCh38:
Chr4:109760372
CFIG58S, G261SAtypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
46.
GRCh37:
Chr4:110723298
GRCh38:
Chr4:109802142
CFIAtypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
47.
GRCh37:
Chr4:110670749
GRCh38:
Chr4:109749593
CFIR317Q, R298Q, R325Q, R114Q, R310QAtypical hemolytic-uremic syndrome with I factor anomaly, Atypical hemolytic-uremic syndrome with I factor anomaly, Age related macular degeneration 13,
Factor I deficiency
Uncertain significance
(Feb 23, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr4:110723127
GRCh38:
Chr4:109801971
CFIM1Vnot provided, Atypical hemolytic-uremic syndrome with I factor anomaly, Factor I deficiency,
Age related macular degeneration 13, Atypical hemolytic-uremic syndrome with I factor anomaly
Uncertain significance
(Dec 23, 2021)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr4:110723067
GRCh38:
Chr4:109801911
CFInot provided, Atypical hemolytic-uremic syndrome with I factor anomalyConflicting interpretations of pathogenicity
(May 17, 2022)
criteria provided, conflicting interpretations
50.
GRCh37:
Chr4:110723062
GRCh38:
Chr4:109801906
CFIAtypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
51.
GRCh37:
Chr4:110687978
GRCh38:
Chr4:109766822
CFInot provided, Atypical hemolytic-uremic syndrome with I factor anomalyConflicting interpretations of pathogenicity
(Mar 19, 2022)
criteria provided, conflicting interpretations
52.
GRCh37:
Chr4:110687947
GRCh38:
Chr4:109766791
CFIK31Qnot provided, Atypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Jul 6, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr4:110687890
GRCh38:
Chr4:109766734
CFIP50Anot provided, Atypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Oct 5, 2022)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr4:110667647
GRCh38:
Chr4:109746491
CFIT184I, T368I, T395I, T387I, T380IAtypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Jul 2, 2019)
no assertion criteria provided
55.
GRCh37:
Chr4:110670404
GRCh38:
Chr4:109749248
CFIC373S, C170S, C354S, C366S, C381SAtypical hemolytic-uremic syndrome with I factor anomalyLikely pathogenic
(Jul 2, 2019)
no assertion criteria provided
56.
GRCh37:
Chr4:110667452
GRCh38:
Chr4:109746296
CFIA249D, A433D, A445D, A460D, A452DAtypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Apr 26, 2019)
no assertion criteria provided
57.
GRCh37:
Chr4:110681459
GRCh38:
Chr4:109760303
CFIC284G, C81GAtypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Sep 6, 2019)
no assertion criteria provided
58.
GRCh37:
Chr4:110687854
GRCh38:
Chr4:109766698
CFIK62EAtypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Jun 5, 2019)
no assertion criteria provided
59.
GRCh37:
Chr4:110667429
GRCh38:
Chr4:109746273
CFIAge related macular degeneration 13, Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly,
not provided
Likely benign
(Oct 28, 2021)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr4:110685687
GRCh38:
Chr4:109764531
CFInot provided, Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome with I factor anomaly
Benign/Likely benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr4:110687829
GRCh38:
Chr4:109766673
CFIN70Tnot provided, Atypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Jun 8, 2022)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr4:110667642
GRCh38:
Chr4:109746486
CFIR389C, R382C, R397C, R186C, R370CAtypical hemolytic-uremic syndrome with I factor anomalyLikely pathogenic
(Sep 28, 2018)
no assertion criteria provided
63.
GRCh37:
Chr4:110682772
GRCh38:
Chr4:109761616
CFIR187*not provided, Atypical hemolytic-uremic syndrome with I factor anomaly, Age related macular degeneration 13,
Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly
Pathogenic/Likely pathogenic
(Sep 7, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr4:110663649
GRCh38:
Chr4:109742493
CFIA511V, A519V, A504V, A308V, A492VAtypical hemolytic-uremic syndrome with I factor anomaly, Age related macular degeneration 13, Factor I deficiency,
not provided, Afibrinogenemia, Atypical hemolytic-uremic syndrome with I factor anomaly,
Age related macular degeneration 13
Uncertain significance
(Mar 30, 2022)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr4:110687833
GRCh38:
Chr4:109766677
CFIK69EInborn genetic diseases, Atypical hemolytic-uremic syndrome with I factor anomaly, Age related macular degeneration 13,
Factor I deficiency, not provided
Uncertain significance
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr4:110687728
GRCh38:
Chr4:109766572
CFIG104RAtypical hemolytic-uremic syndrome with I factor anomalyLikely pathogenic
(Sep 18, 2017)
no assertion criteria provided
67.
GRCh37:
Chr4:110667574
GRCh38:
Chr4:109746418
CFIY411*, Y404*, Y419*, Y208*, Y392*Factor I deficiency, not provided, Age related macular degeneration 13,
Factor I deficiency, Atypical hemolytic-uremic syndrome with I factor anomaly
Likely pathogenic
(Apr 11, 2022)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr4:110662092
GRCh38:
Chr4:109740936
CFIS570T, S563T, S578T, S367T, S551TAtypical hemolytic-uremic syndrome with I factor anomaly, not provided, Atypical hemolytic-uremic syndrome with I factor anomaly,
Age related macular degeneration 13, Factor I deficiency
Uncertain significance
(Oct 14, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr4:110685721
GRCh38:
Chr4:109764565
CFIV152MAtypical hemolytic-uremic syndrome with I factor anomaly, not provided, Atypical hemolytic-uremic syndrome with I factor anomaly,
Age related macular degeneration 13, Factor I deficiency
Uncertain significance
(Sep 9, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr4:110661835
GRCh38:
Chr4:109740679
CFInot provided, Atypical hemolytic-uremic syndrome with I factor anomalyBenign
(Nov 10, 2018)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr4:110723225
GRCh38:
Chr4:109802069
CFIAtypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
72.
GRCh37:
Chr4:110723140
GRCh38:
Chr4:109801984
CFIAtypical hemolytic-uremic syndrome with I factor anomalyBenign
(Jan 13, 2018)
criteria provided, single submitter
73.
GRCh37:
Chr4:110687909
GRCh38:
Chr4:109766753
CFInot provided, Atypical hemolytic-uremic syndrome with I factor anomalyLikely benign
(May 19, 2022)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr4:110687729
GRCh38:
Chr4:109766573
CFInot provided, Atypical hemolytic-uremic syndrome with I factor anomalyLikely benign
(Aug 10, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr4:110687723
GRCh38:
Chr4:109766567
CFInot specified, not provided, Atypical hemolytic-uremic syndrome with I factor anomaly
Benign
(Oct 30, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr4:110687719
GRCh38:
Chr4:109766563
CFIT107AAtypical hemolytic-uremic syndrome with I factor anomaly, Atypical hemolytic-uremic syndrome with I factor anomaly, Factor I deficiency,
Age related macular degeneration 13
Benign/Likely benign
(Feb 4, 2022)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr4:110685770
GRCh38:
Chr4:109764614
CFInot provided, Atypical hemolytic-uremic syndrome with I factor anomalyBenign/Likely benign
(Sep 21, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr4:110685687
GRCh38:
Chr4:109764531
CFInot provided, Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome with I factor anomaly
Benign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr4:110685679
GRCh38:
Chr4:109764523
CFInot provided, Atypical hemolytic-uremic syndrome with I factor anomalyBenign
(Nov 3, 2022)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr4:110682791
GRCh38:
Chr4:109761635
CFIAtypical hemolytic-uremic syndrome with I factor anomaly, Atypical hemolytic-uremic syndrome with I factor anomaly, Factor I deficiency,
Age related macular degeneration 13
Likely benign
(Feb 8, 2022)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr4:110682723
GRCh38:
Chr4:109761567
CFIT203Inot specified, not provided, Atypical hemolytic-uremic syndrome,
Atypical hemolytic-uremic syndrome with I factor anomaly
Conflicting interpretations of pathogenicity
(Oct 29, 2022)
criteria provided, conflicting interpretations
82.
GRCh37:
Chr4:110681505
GRCh38:
Chr4:109760349
CFInot specified, not provided, Factor I deficiency,
Atypical hemolytic-uremic syndrome with I factor anomaly
Benign
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr4:110678946
GRCh38:
Chr4:109757790
CFInot provided, Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome with I factor anomaly
Benign
(Sep 28, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr4:110673662
GRCh38:
Chr4:109752506
CFInot specified, not provided, Atypical hemolytic-uremic syndrome,
Atypical hemolytic-uremic syndrome with I factor anomaly
Conflicting interpretations of pathogenicity
(Oct 26, 2022)
criteria provided, conflicting interpretations
85.
GRCh37:
Chr4:110673648
GRCh38:
Chr4:109752492
CFII306V, I314V, I299V, I103Vnot specified, not provided, Atypical hemolytic-uremic syndrome with I factor anomaly
Likely benign
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr4:110670647
GRCh38:
Chr4:109749491
CFInot provided, Atypical hemolytic-uremic syndrome with I factor anomaly, Atypical hemolytic-uremic syndrome with I factor anomaly,
Factor I deficiency, Age related macular degeneration 13
Benign/Likely benign
(Sep 26, 2022)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr4:110670646
GRCh38:
Chr4:109749490
CFInot provided, Atypical hemolytic-uremic syndrome with I factor anomalyConflicting interpretations of pathogenicity
(Aug 23, 2022)
criteria provided, conflicting interpretations
88.
GRCh37:
Chr4:110670410
GRCh38:
Chr4:109749254
CFIG371V, G379V, G364V, G168V, G352VAtypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
89.
GRCh37:
Chr4:110667601
GRCh38:
Chr4:109746445
CFIKidney disorder, not provided, Atypical hemolytic-uremic syndrome with I factor anomaly,
Atypical hemolytic-uremic syndrome with I factor anomaly, Factor I deficiency, Age related macular degeneration 13
Benign/Likely benign
(Oct 31, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr4:110667590
GRCh38:
Chr4:109746434
CFIR406H, R399H, R414H, R203H, R387Hnot provided, Atypical hemolytic-uremic syndrome with I factor anomaly, Focal segmental glomerulosclerosis
Benign
(Oct 25, 2022)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr4:110667561
GRCh38:
Chr4:109746405
CFII416L, I424L, I409L, I213L, I397Lnot specified, not provided, Atypical hemolytic-uremic syndrome with I factor anomaly
Conflicting interpretations of pathogenicity
(Oct 31, 2022)
criteria provided, conflicting interpretations
92.
GRCh37:
Chr4:110667485
GRCh38:
Chr4:109746329
CFIK441R, K434R, K449R, K238R, K422RInborn genetic diseases, not specified, not provided,
Atypical hemolytic-uremic syndrome, Thrombotic microangiopathy, Atypical hemolytic-uremic syndrome with I factor anomaly,
Atypical hemolytic-uremic syndrome with I factor anomaly, Factor I deficiency, Age related macular degeneration 13
Conflicting interpretations of pathogenicity
(Oct 10, 2022)
criteria provided, conflicting interpretations
93.
GRCh37:
Chr4:110667426
GRCh38:
Chr4:109746270
CFIF461L, F454L, F469L, F258L, F442LAtypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
94.
GRCh37:
Chr4:110667397
GRCh38:
Chr4:109746241
CFInot provided, Atypical hemolytic-uremic syndrome with I factor anomalyBenign
(Oct 3, 2022)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr4:110667378
GRCh38:
Chr4:109746222
CFID477H, D485H, D470H, D274H, D458Hnot provided, Atypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Sep 24, 2021)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr4:110667373
GRCh38:
Chr4:109746217
CFIAtypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
97.
GRCh37:
Chr4:110667370
GRCh38:
Chr4:109746214
CFInot provided, Atypical hemolytic-uremic syndrome with I factor anomaly, Atypical hemolytic-uremic syndrome with I factor anomaly,
Factor I deficiency, Age related macular degeneration 13
Benign/Likely benign
(Nov 22, 2021)
criteria provided, multiple submitters, no conflicts
98.
GRCh37:
Chr4:110663738
GRCh38:
Chr4:109742582
CFInot provided, Atypical hemolytic-uremic syndrome with I factor anomaly, Atypical hemolytic-uremic syndrome with I factor anomaly,
Factor I deficiency, Age related macular degeneration 13
Benign/Likely benign
(Oct 21, 2022)
criteria provided, multiple submitters, no conflicts
99.
GRCh37:
Chr4:110663665
GRCh38:
Chr4:109742509
CFIK506Q, K499Q, K514Q, K303Q, K487QAtypical hemolytic-uremic syndrome with I factor anomalyUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
100.
GRCh37:
Chr4:110662220
GRCh38:
Chr4:109741064
CFIKidney disorder, not provided, Atypical hemolytic-uremic syndrome with I factor anomaly,
Atypical hemolytic-uremic syndrome with I factor anomaly, Factor I deficiency, Age related macular degeneration 13
Benign/Likely benign
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination